Peter V. Robinson
Enable Biosciences (United States)(US)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Pancreatic function and diabetes, Diabetes and associated disorders, SARS-CoV-2 detection and testing, COVID-19 Clinical Research Studies
Most-Cited Works
- → Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation(2015)84 cited
- → Ultrasensitive Antibody Detection by Agglutination-PCR (ADAP)(2016)78 cited
- → A serological assay to detect SARS-CoV-2 antibodies in at-home collected finger-prick dried blood spots(2020)75 cited
- → Glyco-seek: Ultrasensitive Detection of Protein-Specific Glycosylation by Proximity Ligation Polymerase Chain Reaction(2016)63 cited
- → Antibody detection by agglutination–PCR (ADAP) enables early diagnosis of HIV infection by oral fluid analysis(2018)48 cited
- → Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCR(2020)46 cited
- → Sensitive and Specific Detection of SARS-CoV-2 Antibodies Using a High-Throughput, Fully Automated Liquid-Handling Robotic System(2020)32 cited
- → Multiplex agglutination-PCR (ADAP) autoantibody assays compared to radiobinding autoantibodies in type 1 diabetes and celiac disease(2022)31 cited
- → Detection of SARS-CoV-2 neutralizing antibodies with a cell-free PCR assay(2020)15 cited
- → Automation of a multiplex agglutination-PCR (ADAP) type 1 diabetes (T1D) assay for the rapid analysis of islet autoantibodies(2022)14 cited